BHT-3009 0.5 mg ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	1

13. 多発性硬化症／視神経脊髄炎

---

臨床試験数 : 3,342 /  薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00382629 (ClinicalTrials.gov)	February 2006	27/9/2006	BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis	BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis	Relapsing Remitting Multiple Sclerosis	Drug: BHT-3009 0.5 mg;Drug: BHT-3009 1.5 mg;Drug: Placebo	Bayhill Therapeutics	NULL	Completed	18 Years	55 Years	Both	252	Phase 2	NULL